|Bid||5.80 x 0|
|Ask||5.82 x 0|
|Day's Range||5.51 - 5.87|
|52 Week Range||2.65 - 10.08|
|Beta (5Y Monthly)||2.09|
|PE Ratio (TTM)||50.09|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Should Aphria's move from the NYSE to the NASDAQ mean anything for the cannabis stock's share price?The post What Aphria's Move From the NYSE to the NASDAQ Means for Stock Investors appeared first on The Motley Fool Canada.
Some of the top TSX cannabis stocks have seen a consistent surge in the last few months. Do you own these in your portfolio?The post Market Rally: Top TSX Cannabis Stocks for June 2020 appeared first on The Motley Fool Canada.
Some are high, some are low, so let's see where these three top cannabis producers fall with a $10,000 investment.The post Here’s How Much $10,000 Invested in Aurora, Canopy and Aphria Is Worth Today appeared first on The Motley Fool Canada.
Veeva Systems' (VEEV) core Subscription business segment performed impressively in Q1.
Investors seeking long-term upside in the Canadian legal cannabis space have a strong play with Aphria (TSX:APHA)(NYSE:APHA).The post Is Aphria (TSX:APHA) the Best Canadian Cannabis Stock? appeared first on The Motley Fool Canada.
Hexo Corp (TSX:HEXO)(NYSE:HEXO) and Aphria Inc (TSX:APHA)(NYSE:APHA) could be better buys in the growing industry.The post Interested in Aurora Cannabis Stock? Try These Companies Instead appeared first on The Motley Fool Canada.
Investor confidence is high in Inogen (INGN) stock, thanks to solid prospects.
This development, which is in response to the challenges brought on by the pandemic, is expected to boost Varian's (VAR) Oncology segment.
Baxter (BAX) receives the CE marking and regulatory approval for the Evo IQ Syringe Infusion system that will help in optimizing efficiency for clinicians.
Aphria (NYSE: APHA) will no longer be traded through that most classic of American financial institutions, the New York Stock Exchange (NYSE). On Tuesday, the company announced that its shares will move to the Nasdaq (NASDAQ: NDAQ), beginning at market open on Monday, June 8. The stock will retain its current ticker symbol of APHA.
Aphria and IIPR are two stocks that are well poised to take advantage of the expanding cannabis market. The post Market Recovery 2020: 2 Pot Stocks to Buy on the Rebound appeared first on The Motley Fool Canada.
Henry Schein (HSIC) registers dismal performance within Dental business on suspension of non-emergency procedures in response to the pandemic.
Cannabis producer Aphria is moving its U.S. stock listing from the New York Stock Exchange to the Nasdaq Global Select Market in bid to cut costs.
Veeva Systems' (VEEV) fiscal first-quarter results are likely to reflect solid show by its segments and robust product portfolio.
Shares of Green Growth Brands plunged more than 70 per cent to just above a penny on Wednesday after the cannabis firm announced it has filed for creditor protection.
(Bloomberg) -- Green Growth Brands Inc., a cannabis company that made a failed pursuit for Aphria Inc., filed for bankruptcy protection after warning investors it was in “serious financial difficulty.”The company said in a statement Wednesday its “severe liquidity crisis in the face of material matured and maturing debt” was made worse by the Covid-19 pandemic.“The continuing operations of the company are dependent upon its ability to continue to raise adequate financing, to commence profitable operations, and to repay its liabilities arising from normal business operations as they become due,” Green Growth said. It requested court protection through the Companies’ Creditors Arrangement Act in Canada. Ernst & Young Inc. was appointed as the monitor in the proceedings.All Js Greenspace LLC, one of GGB’s existing secured lenders, agreed to a debtor-in-possession loan facility of as much as $7.2 million, Green Growth said. Its shares tumbled as much as 64% to 2 Canadian cents in Toronto.Green Growth made a splashy attempt to take over one of the biggest players in the Canadian cannabis industry with a C$2.4 billion hostile bid for Aphria in January 2019. That came after a short-seller attack triggered a plunge that erased more than half of Aphria’s market value. Since then, Aphria has posted three consecutive quarters of profitability on an Ebitda basis.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
McKesson's (MCK) fiscal fourth-quarter 2020 results benefit from strong segmental performance.
A big challenge with investing in pot stocks is that bad returns by one company can send all the others into a tailspin. Aphria (NYSE: APHA) is a good example. Profits are rare in the cannabis industry.
Medtronic's (MDT) new cannula will complement its entire portfolio of balloon kyphoplasty products, including Kyphon Xpander II Inflatable Bone Tamps.